ATAD2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.096400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.876220E-01
Normal-vs-Stage2
3.205600E-01
Normal-vs-Stage3
1.722950E-01
Normal-vs-Stage4
3.217800E-01
Stage1-vs-Stage2
6.106200E-01
Stage1-vs-Stage3
2.574300E-02
Stage1-vs-Stage4
9.078600E-01
Stage2-vs-Stage3
2.13829998152448E-09
Stage2-vs-Stage4
5.691800E-01
Stage3-vs-Stage4
1.102570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.117600E-01
Normal-vs-AfricanAmerican
1.958790E-01
Normal-vs-Asian
3.260300E-02
Caucasian-vs-AfricanAmerican
6.281200E-01
Caucasian-vs-Asian
4.188600E-01
AfricanAmerican-vs-Asian
3.831200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.141400E-01
Normal-vs-Female
3.062400E-01
Male-vs-Female
7.997400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.250800E-01
Normal-vs-Age(41-60Yrs)
3.717800E-01
Normal-vs-Age(61-80Yrs)
2.851200E-01
Normal-vs-Age(81-100Yrs)
2.889600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.158000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.824600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.692800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.901520E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.744950E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.631600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.053400E-01
Normal-vs-Daily Drinker
2.796400E-01
Normal-vs-Weekly Drinker
2.458300E-02
Normal-vs-Occasional Drinker
2.971800E-01
Normal-vs-Social Drinker
3.208200E-01
Non Drinker-vs-Daily Drinker
6.174800E-01
Non Drinker-vs-Weekly Drinker
3.935800E-01
Non Drinker-vs-Occasional Drinker
8.804600E-01
Non Drinker-vs-Social Drinker
8.192200E-01
Daily Drinker-vs-Weekly Drinker
6.831400E-01
Daily Drinker-vs-Occasional Drinker
7.333400E-01
Daily Drinker-vs-Social Drinker
5.066800E-01
Weekly Drinker-vs-Occasional Drinker
4.663000E-01
Weekly Drinker-vs-Social Drinker
3.289800E-01
Occasional Drinker-vs-Social Drinker
6.984400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.021180E-01
Normal-vs-Grade 2
7.240300E-03
Normal-vs-Grade 3
4.396500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.530000E-01
Grade 1-vs-Grade 3
1.673790E-01
Grade 1-vs-Grade 4
1.021180E-01
Grade 2-vs-Grade 3
1.555420E-01
Grade 2-vs-Grade 4
7.240300E-03
Grade 3-vs-Grade 4
4.396500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.848800E-01
Normal-vs-NonDiabetic
2.899200E-01
Diabetic-vs-NonDiabetic
8.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.904200E-01
Normal-vs-NoPancreatitis
2.897200E-01
Pancreatitis-vs-NoPancreatitis
9.440000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.890200E-01
Normal-vs-N1
3.230200E-01
N0-vs-N1
2.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.813000E-01
Normal-vs-TP53-NonMutant
3.348000E-01
TP53-Mutant-vs-TP53-NonMutant
2.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
